MedTrace Logo

Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery

NCT02919436 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 610

Last updated 2022-02-17

Study results available
· View outcomes & findings →

Summary

Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.

Conditions

  • Post-operative Urinary Retention

Interventions

DRUG

Tamsulosin

Active drug

DRUG

Placebo

Lactose-filled capsules identical to active drug

Sponsors & Collaborators

  • MaineHealth

    collaborator OTHER

  • Anand Rughani, MD

    lead OTHER

Principal Investigators

  • Anand Rughani, MD · MaineHealth

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-01-31
Completion
2020-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02919436 on ClinicalTrials.gov